Practice guidelines for evaluation of fever in returning travelers and migrants

Journal of Travel Medicine

Volumn 10, Issue SUPPL. 2, 2003, Pages S25-S45

  D'Acremont, Valérie ^a   Burnand, Bernard ^b   Ambresin, Anne Emmanuelle ^a   Genton, Blaise ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c Swiss Tropical Institute ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; AMBULATORY CARE; DATA BASE; DOCUMENTATION; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FEVER; IMMIGRANT; INFECTION; LIBRARY; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; OUTCOMES RESEARCH; PRACTICE GUIDELINE; REVIEW; TRAVEL; TROPICAL DISEASE; TROPICS;

EID: 0037526419     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2003.35132     Document Type: Review

References (131)

1. Steffen R, Rickenbach M, Wilhelm U, et al. Health problems after travel to developing countries. J Infect Dis 1987; 156:84-91.
2. Hill DR. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med 2000; 7:259-266.
3. Humar A, Keystone J. Evaluating fever in travellers returning from tropical countries. BMJ 1996; 312:953-956.
4. D'Acremont V, Landry P, Mueller I, et al. Clinical and laboratory predictors of imported malaria in an outpatient setting: an aid to medical decision making in returning travelers with fever. Am J Trop Med Hyg 2002; 66:481-486.
5. Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 1998; 27:142-149.
6. www.cyinfo.com/resources.htm (Last accessed 11.03.03).
7. Genton B, D'Acremont V. Clinical features of malaria in returning travelers and migrants. In: Schlagenhauf P, ed. Travelers' malaria. Hamilton, ON: BC Decker; 2001:371-392.
8. Svenson JE, MacLean JD, Gyorkos TW, Keystone J. Imported malaria. Clinical presentation and examination of symptomatic travelers. Arch Intern Med 1995; 155:861-868.
9. Castelli F, Matteelli A, Caligaris S, et al. Malaria in migrants. Parassitologia 1999; 41:261-265.
10. D'Acremont V, Landry P, Pécoud A, et al. Is clinical presentation of malaria different in migrants than in nonmigrants? Abstract Book of the Annual Congress of the Swiss Society of Tropical Medicine and Parasitology, Solothurn, Switzerland 1999; 4-11.
11. Ebnöther E. Reisefieber-Fieber nach Reisen. Primary Care 2001; 1:361-363.
12. CATMAT. Fever in the international traveller - initial assessment guidelines. Can Commun Dis Rep 1997; 23.
13. D'Acremont V, Landry P, Darioli R, et al. Treatment of imported malaria in an ambulatory setting: prospective study. BMJ 2002; 324:875-877.
14. www.cebm.net/levels_of_evidence.asp#levels (Last accessed 11.03.03).
15. World Health Organization, Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94 1(Suppl):S1-S90.
16. Bignardi GE. The new viral haemorrhagic fever infection control guidelines. J Hosp Infect 1998; 39:169-172.
17. ter Meulen J. Response to haemorrhagic fevers in Europe. Lancet 2000; 356(Suppl):S64.
18. Colville A, Stansfield RE, Bignardi G, Hovenden J. Fever from the tropics. ACDP guidelines are impractical. BMJ 1998; 317:1389-1390.
19. Formentry P, Hatz C, Le Guenno B, et al. Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation. J Infect Dis 1999; 179(Suppl):S48-S53.
20. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1 + published correction):1-31.
21. Hatz CF. Aktuelle malaria therapie in der Schweiz. Schweiz Med Wochenschr 1994; 124:2249-2259.
22. Whitty CJ, Carroll B, Armstrong M, et al. Utility of history, examination and laboratory tests in screening those returning to Europe from the tropics for parasitic infection. Trop Med Int Health 2000; 5:818-823.
23. Visser LG, Polderman AM, Stuiver PC. Outbreak of schistosomiasis among travelers returning from Mali, West Africa. Clin Infect Dis 1995; 20:280-285.
24. Doherty JF, Moody AH, Wright SG. Katayama fever: an acute manifestation of schistosomiasis. BMJ 1996; 313:1071-1072.
25. Cetron MS, Chitsulo L, Suilivan JJ, et al. Schistosomiasis in Lake Malawi. Lancet 1996; 348:1274-1278.
26. Bou A, Gascon J, Eugenia VM, Corachan M. Fiebre de Katayama en turistas españoles: análisis de 25 casos. Med Clin (Barc) 2001; 116:220-222.
27. World Health Organization. http://www.who.int/ctd/shisto/ epidemio.htm (Last accessed 11.03.03).
28. Day JH, Grant AD, Doherty JF, et al. Schistosomiasis in travellers returning from sub-Saharan Africa. BMJ 1996; 313:268-269.
29. Manson's tropical diseases. In: Cook GC, ed. London, UK: Saunders; 1996.
30. Elcuaz R, Armas M, Ramirez M, et al. [Outbreak of schistosomiasis in a group a travellers returning from Burkina Faso]. Enferm Infecc Microbiol Clin 1998; 16:367-369.
31. Loutan L, Farinelli T, Robert CF. Schistosomiase aiguë ou syndrome do Katayama: à propos de 2 mini-épidémies. Schweiz Med Wochenschr 1996; 126:1482-1486.
32. Blanchard TJ, Milne LM, Pollok R, Cook GC. Early chemotherapy of imported neuroschistosomiasis. Lancet 1993; 341:959.
33. Cooke GS, Lalvani A, Gleeson FV, Conlon CP. Acute pulmonary schistosomiasis in travelers returning from Lake Malawi, sub-Saharan Africa. Clin Infect Dis 1999; 29:836-839.
34. Harries AD, Cook GC. Acute schistosomiasis (Katayama fever): clinical deterioration after chemotherapy. J Infect 1987; 14:159-161.
35. Utzinger J, N'Goran EK, N'Dri A, et al. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 2000; 355:1320-1325.
36. Centers for Disease Control and Prevention. Outbreak of leptospirosis among white-water rafters - Costa Rica, 1996. JAMA 1997; 278:808-809.
37. Antony SJ. Leptospirosis - an emerging pathogen in travel medicine: a review of its clinical manifestations and management. J Travel Med 1996; 3:113-118.
38. van Crevel R, Speelman P, Gravekamp C, Terpstra WJ. Leptospirosis in travelers. Clin Infect Dis 1994; 19:132-134.
39. Magill AJ. Fever in the returned traveler. Infect Dis Clin North Am 1998; 12:445-469.
40. Olszyna DP, Jáspars R, Speelman P, et al. [Leptospirosis in the Netherlands, 1991-1995]. Ned Tijdschr Geneeskd 1998; 142:1270-1273.
41. Update: outbreak of acute febrile illness among athletes participating in Eco-Challenge-Sabah 2000 - Borneo, Malaysia, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:21-24.
42. Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14:296-326.
43. Yersin C, Bovet P, Smits HL, Perolat P. Field evaluation of a onestep dipstick assay for the diagnosis of human leptospirosis in the Seychelles. Trop Med Int Health 1999; 4:38-45.
44. Pendle S, Sacks LV. Primary HIV infection diagnosed in South Africa masquerading as another tropical disease. Trans R Soc Trop Med Hyg 1998; 92:425-427.
45. Gagneux OP, Blochliger CU, Tanner M, Hatz CF. Malaria and casual sex: what travelers know and how they behave. J Travel Med 1996; 3:14-21.
46. Berrey MM, Schacker T, Collier AC, et al. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. J Infect Dis 2001; 183:1466-1475.
47. Brucellosis associated with unpasteurized milk products abroad. Wkly Epidemiol Rec 1995; 70:308-309
48. Luzzi GA, Brindle R, Sockett PN, et al. Brucellosis: imported and laboratory-acquired cases, and an overview of treatment trials. Trans R Soc Trop Med Hyg 1993; 87:138-141.
49. Yagupsky P. Detection of Brucellae in blood cultures. J Clin Microbiol 1999; 37:3437-3442.
50. Dankner WM, Waecker NJ, Essey MA, et al. Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore) 1993; 72:11-37.
51. Strickland GT. Fever in the returned traveler. Med Clin North Am 1992; 76:1375-1392.
52. Felton JM, Bryceson AD. Fever in the returning traveller. Br J Hosp Med 1996; 55:705-711.
53. Misra S, Diaz PS, Rowley AH. Characteristics of typhoid fever in children and adolescents in a major metropolitan area in the United States. Clin Infect Dis 1997; 24:998-1000.
54. McFarland JM, Baddour LM, Nelson JE, et al. Imported yellow fever in a United States citizen. Clin Infect Dis 1997; 25:1143-1147.
55. Teichmann D, Grobusch MP, Wesselmann H, et al. A haemorrhagic fever from the Cote d'Ivoire. Lancet 1999; 354:1608.
56. Borgnolo G, Hailu B, Ciancarelli A, et al. Louse-borne relapsing fever. A clinical and an epidemiological study of 389 patients in Asella Hospital, Ethiopia. Trop Geogr Med 1993; 45:66-69.
57. Dworkin MS, Anderson DE Jr, Schwan TG, et al. Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis 1998; 26:122-131.
58. Schwartz E, Moskovitz A, Potasman I, et al. Changing epidemiology of dengue fever in travelers to Thailand. Eur J Clin Microbiol Infect Dis 2000; 19:784-786.
59. Wittesjo B, Eitrem R, Niklasson B. Dengue fever among Swedish tourists. Scand J Infect Dis 1993; 25:699-704.
60. Schwartz E, Mendelson E, Sidi Y. Dengue fever among travelers. Am J Med 1996; 101:516-520.
61. Badiaga S, Delmont J, Brouqui P, et al. Dengue importée: une étude de 44 cas observés de 1994 à 1997 dans 9 centres universitaires. Pathol Biol (Paris) 1999; 47:539-542.
62. Shirtcliffe P, Cameron E, Nicholson KG, Wiselka MJ. Don't forget dengue! Clinical features of dengue fever in returning travellers. J R Coll Physicians Lond 1998; 32:235-237.
63. Jelinek T, Dobler G, Holscher M, et al. Prevalence of infection with dengue virus among international travelers. Arch Int Med 1997; 157:2367-2370.
64. Mahe A, Lamaury I, Strobel M. Manifestations muco-cutanées de la dengue. Presse Medicale 1998; 27:1909-1913.
65. Imported dengue - United States, 1995. MMWR Morb Mortal Wkly Rep 1996; 45:988-991.
66. Schwartz E, Mileguir F, Grossman Z, Mendelson E. Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. J Clin Virol 2000; 19:169-173.
67. Cuzzubbo AJ, Vaughn DW, Nisalak A, et al. Comparison of PanBio Dengue Duo IgM and IgG capture ELISA and venture technologies dengue IgM and IgG dot blot. J Clin Virol 2000; 16: 135-144.
68. World Health Organization. http://www.who.int/emc/ diseases/ebola/Denguepublicadon/index.htwl. (Last accessed 11.03.03).
69. Puente S, Lago M, Subirats M, et al. Spotted fever attributable to Rickettsia conorii: ten cases imported from subSaharan Africa. J Travel Med 1995; 2:204-205.
70. Marschang A, Nothdurft HD, Kumlien S, von Sonnenburg F. Imported rickettsioses in German travelers. Infection 1995; 23:94-97.
71. Raoult D, Fournier PE, Fenollar F, et al. Rickettsia africae, a tickborne pathogen in travelers to sub-Saharan Africa. N Engl J Med 2001; 344:1504-1510.
72. Cascio A, Dones P, Romano A, Titone L. Clinical and laboratory findings of boutonneuse fever in Sicilian children. Eur J Pediatr 1998; 157:482-486.
73. Smoak BL, McClain JB, Brundage JF, et al. An outbreak of spotted fever rickettsiosis in US Army troops deployed to Botswana. Emerg Infect Dis 1996; 2:217-221.
74. Loutan L. Fever when returning from the tropics. Médecine & Hygiène 1999; 57:1144-1150.
75. O'Brien D, Tobin S, Brown GV, Torresi J. Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis 2001 33:603-609.
76. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998; 158:633-638.
77. Mathieu JJ, Henning KJ, Bell E, Frieden TR. Typhoid fever in New York City, 1980 through 1990. Arch Int Med 1994; 154:1713-1718.
78. Girgis NI, Butler T, Frenck RW, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999; 43:1441-1444.
79. Ackers ML, Puhr ND, Tauxe RV, Mintz ED. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA 2000; 283:2668-2673.
80. Memon IA, Billoo AG, Memon HI. Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children. South Med J 1997; 90:1204-1207.
81. Frenck RW Jr, Nakhla I, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 2000; 31:1134-1138.
82. Measles - United States, 1999. MMWR Morb Mortal Wkly Rep 2000; 49:557-560.
83. Doherty JF, Grant AD, Bryceson AD. Fever as the presenting complaint of travellers returning from the tropics. Q J M 1995; 88:277-281.
84. Klein JL, Millman GC. Prospective, hospital based study of fever in children in the United Kingdom who had recently spent time in the tropics. BMJ 1998; 316:1425-1426.
85. Wolfe MS, Tuazon C, Schultz R. Bubonic plague - an imported case. Am J Trop Med Hyg 1999; 61(Suppl 3):227-22.
86. Bryan R, Waskin H, Richards F. African trypanosomiasis in American travelers: a 20-year review. Travel Medicine: Proceedings of the First Conference on International Travel Medicine, Zurich, Switzerland, 1988; 385-388.
87. Ripamonti D, Massari M, Arici C, et al. African sleeping sickness in tourists returning from Tanzania: the first 2 Italian cases from a small outbreak among European travelers. Clin Infect Dis 2002; 34:E18-E22.
88. Maguire JH. Epidemiologic considerations in the evaluation of undifferentiated fever in a traveler returning from Latin America or the Caribbean. Curr Clin Topics Infect Dis 1993; 13:26-56.
89. Suh KN, Kozarsky PE, Keystone JS. Evaluation of fever in the returned traveler. Med Clin North Am 1999; 83:997-1017.
90. Schwartz E, Rozenman J, Perelman M. Pulmonary manifestations of early schistosome infection among nonimmune travelers. Am J Med 2000; 109:718-722.
91. Ong RK, Doyle RL. Tropical pulmonary eosinophilia. Chest 1998; 113:1673-1679.
92. Vaylet F, Grassin F, Le Vagueresse R, et al. Parasitic eosinophilic lungs. Rev Pneumol Clin 1998; 54:329-339.
93. Magnaval JF. Apport du laboratoire au diagnostic des hyperéosinophilies. Medecine Tropicale 1998; 58(Suppl 4):493-498.
94. Ellis CJ. Imported fevers. J R Coll Physicians Lond 1995; 29:422-423.
95. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infect Dis Soc Amer Clin Infect Dis 2000; 31:347-382.
96. Habib NA, Behrens RH. Respiratory infections in the traveler. Curr Opin Pulm Med 2000; 6:246-249.
97. Cobelens FG, van Deutekom H, Draayer-Jansen IW, et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000; 356:461-465.
98. Gascon J, Torres JM, Luburich P, et al. Imported histoplasmosis in Spain. J Travel Med 2000; 7:89-91.
99. Valdez H, Salata RA. Bat-associated histoplasmosis in returning travelers: case presentation and description of a cluster. J Travel Med 1999; 6:258-260.
100. Dance DA, Smith MD, Aucken HM, Pitt TL. Imported melioidosis in England and Wales. Lancet 1999; 353:208.
101. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997; 46(RR-10):1-55.
102. Diphtheria acquired by US citizens in the Russian Federation and Ukraine - 1994. MMWR Morb Mortal Wkly Rep 1995; 44:237, 243-244.
103. Gear JH. Clinical aspects of African viral hemorrhagic fevers. Rev Infect Dis 1989; 11(Suppl 4):S777-S782.
104. Caurnes E, Ehya N, Nguyen J, Bricaire F. Typhoid and paratyphoid fever: a 10-year retrospective study of 41 cases in a Parisian hospital. J Travel Med 2001; 8:293-297.
105. Begue P, Ayivi B, Quinet B, Ter Sakarian M. Le paludisme d'importations chez l'enfant: analyse épidémiologique, clinique et thérapeutique. A propos de 70 cas observés dans un hôpital pédiatrique parisien. Bull Soc Pathol Exot 1991; 84:154-163.
106. Hughes MA, Petri WA Jr. Amebic liver abscess. Infect Dis Clin North Am 2000; 14:565-82, viii.
107. Lee KC, Yamazaki O, Hamba H, et al. Analysis of 69 patients with amebic liver abscess. J Gastroenterol 1996; 31:40-45.
108. Weinke T, Scherer W, Neuber U, Trautmann M. Clinical features and management of amebic liver abscess. Experience from 29 patients. Klinische Wochenschrift 1989; 67:415-420.
109. Kimura K, Stoopen M, Reeder MM, Moncada R. Amebiasis: modern diagnostic imaging with pathological and clinical correlation. Semin Roentgenol 1997; 32:250-275.
110. Jiang ZD, Lowe B, Verenkar MP, et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 2002; 185:497-502.
111. Steffen R, Collard F, Tornieporth N, et al. Epidemiology, etiology and impact of traveler's diarrhea in Jamaica. JAMA 1999; 281:811-817.
112. von Sonnenburg F, Tornieporth N, Waiyaki P, et al. Risk and aetiology of diarrhoea at various tourist destinations. Lancet 2000; 356:133-134.
113. Mac Kenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994; 331:161-167.
114. Okhuysen PC. Traveler's diarrhea due to intestinal protozoa. Clin Infect Dis 2001; 33:110-114.
115. Herwaldt BL, Ackers ML. An outbreak in 1996 of cyclosporiasis associated with imported raspberries. The Cyclospora Working Group. N Engl J Med 1997; 336:1548-1556.
116. Soave R, Herwaldt BL, Relman DA. Cyclospora. Infect Dis Clin North Am 1998; 12(1):1-12.
117. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331-351.
118. De Bruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst Rev 2000; (3):CD002242.
119. Ericsson CD,Johnson PC, DuPont HL, et al. Ciprofloxacin of trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. Ann Intern Med 1987; 106:216-220.
120. Threlfall EJ, Ward LR, Skinner JA, et al. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 1999; 353:1590-1591.
121. Kuschner RA, Trofa AF, Thomas RJ, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995; 21:536-541.
122. Gomi H, Jiang ZD, Adachi JA, Ashley D, et al. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother 2001; 45:212-216.
123. Liu LX, Weller PF. Approach to the febrile traveler returning from Southeast Asia and Oceania. Current Clinical Topics in Infectious Diseases 1992; 12:138-164.
124. Richter J, Freise S, Mull R, Millan JC. Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole. Trop Med Int Health 1999;4:774-781.
125. Karabinis A, Herson S, Brucker G, et al. [Fasciolar hepatic abscesses: value of hepatic ultrasonography. Apropos of 3 cases]. Ann Med Interne (Paris) 1985; 136:575-578.
126. Melero M, Rigou RC, Lloveras J, Gennaro O. [Hepatic fascioliasis. Uncommon cause of prolonged febrile syndrome with hypereosinophilia and hypodense images on computed tomography of the liver]. Medicina (B Aires) 1991; 51:244-248.
127. Graham CS, Brodie SB, Weller PF. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clin Infect Dis 2001; 33:1-5.
128. Jeannel D, Tuppin P, Brucker G, et al. Imported and autochthonous kalaazar in France. BMJ 1991; 303:336-338.
129. Amato Neto V. Leishmaniose visceral com periodo de incubacao de, pelo menos, quatro anos. Rev Inst Med Trop Sao Paulo 1978; 20:312-314.
130. El Haouri M, Erragragui Y, Sbai M, et al. Filariose cutanée à Loa Loa: 26 cas marocains d'importation. Ann Dermatol Venereol 2001; 128:899-902.
131. Okhuysen PC. Onchocerciasis in an expatriate living in Cameroon. J Travel Med 1997; 4:11-13.